April 26, 2002
Yoli Has Recalled Mini Jelly Snack Cups
Chicago, IL (SafetyAlerts)
- The Food and Drug Administration (FDA) said that Yoli, Inc. has recalled
3,115 bags of mini jelly candies (or mini-cup gel candy) because these
products present a choking hazard. The product is distributed in bags which
read in part; "Mi Costenita . . . Gelatinas Coconut Jelly" to retail
establishments in Illinois, Michigan, Ohio, Indiana, Tennessee, Arkansas,
Missouri, Mississippi, Kansas, Alabama, Georgia, North Carolina and Wisconsin.
Each mini jelly cup is about the size of single-serve coffee creamer.
These candies contain the ingredient "konjac" (also known as conjac,
konnyaku, yam flour, or glucomannan). The Consumer Product Safety Commission
and the Food and Drug Administration consider this type of candy to pose a
serious choking risk, particularly to infants, children and the elderly.
There have been six children's deaths from choking associated with this,
type of jelly candy throughout the United States in recent years. There have
also been reports of deaths in other countries.
"FDA is committed to protecting the public from these candies, which clearly
present a choking hazard," said Dr. Lester M. Crawford, FDA Deputy
The candies come in 16.7-17 gram individual serving sealed plastic cups that
are contained in bags of six. Consumers are urged to return this product to
the place of purchase. Consumers with questions may call Yoli, Inc at
In August and October 2001, the FDA issued general warnings against
consuming mini-cup gel candies that contain the ingredient "konjac." Other
firms recalled gel candies. In October 2001, the agency issued an Import
Alert to detain this candy at the port prior to entry. Import Alerts
identify problem commodities and communicate guidance to FDA field offices
and the importing community for detention of products that appear to be in
violation of the law. However, candies imported prior to the import alert
are still in the US market.
This type of candy is sold under various brand names and are distributed by
various companies. The FDA continues to investigate this issue.